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The present paper describes a marked induction of liver microsomal cytochrome P-450 and cytosolic
DT-diaphorase to cause possible disorder of steroid homeostasis and promotion of carcinogenicity of
4-nitroquinoline N-oxide (4-NQO) in rats by pretreatment with 3,4,5,3',4'-pentachlorobiphenyl (PenCB) or
2,3,4,7,8-pentachlorodibenzofuran (PenCDF). The animals were sacrificed 5 days after the pretreatment.
These induction experiments showed that 7a-hydroxylation ofboth progesterone and testosterone in liver
microsomes was selectively increased to a great extent, but hydroxylations at the 2a-, 6f- and 16a-positions
were depressed, together with 5a-reduction. From the same microsomes, three of the strongly induced
P450 isozymes, i.e., high- and low-spin P-448s and P452, were purified. The last isozyme was most
responsible for 7a-hydroxylation of testosterone.
The pretreatment, also increased activity ofDT-diaphorase and reduction of4-NQO about 10-fold in liver
9000g supernatants. This reduction of4-NQO was solely catalyzed by DT-diaphorase and the only product
was 4-hydroxylaminoquinoline N-oxide, aproximate carcinogen, indicating that the pretreatment strongly
increased production ofa proximate carcinogen from 4-NQO. Such an enhancement ofthe metabolic acti-
vation of4-NQO by the pretreatment was also observed to some extent in the lung and the skin. Persistency
of PenCB and PenCDF in the liver of rats was also discussed.
Introduction
Polychlorinated biphenyls (PCBs) and polychlorinated
dibenzofurans (PCDFs) are well known to be major
causalagents ofYusho and alsowidespread environmen-
tal contaminants that have a potent inductive effect on
liver microsomal mixed-function oxidases (MFO) (1). In
a series of studies on these polychlorinated aromatic
hydrocarbons, we found that some congeners that were
categorized as 3-methylcholanthrene (MC)-type, but
not phenobarbital (PB)-type in terms of inductive
effects, all exerted severely toxic effects in rats, includ-
ing decrease ofthe body weight, atrophy ofthe thymus
and spleen and lipid accumulation in the liver (2,3). In
addition, pretreatment of rats with these congeners
resulted inpreferential induction ofnot only microsomal
cytochrome P-448, but also cytosolic DT-diaphorase,
and the toxic potencies were correlated well with the
activities of benzo[a]pyrene 3-hydroxylase and DT-
diaphorase induced (2,3). As the representatives for
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such PCBs and PCDFs possessing extremely high
toxicity and strong ability for MC-type induction,
3,4,5,3',4'-pentachlorobiphenyl (PenCB) and 2,3,4,7,8-
pentachlorodibenzofuran (PenCDF) would be the best
candidates.
Presently, the mechanism responsible for such a cor-
relation has not been identified. However, this could be
explained atleastin partbythe followingtwo ways. The
first is a direct toxic effect through a disturbance of
certain intermediary metabolic paths that may be
caused by the marked increase ofabove enzymes over a
long period, because these enzymes have an important
role in intermediary metabolism as well as in drug
metabolism. Forinstance, the steroidmetabolismmight
be disturbed by abnormal changes ofthe content ratios
ofmultipleforms ofcytochrome P-450thatwere induced
by pretreatment with PenCB and PenCDF In Yusho
patients, quite a high incidence of menstrual cycle
irregularities, dysmenorrhea and altered serum levels
of ketosteroids occurred (4). A second mechanism for
the action of PenCB and PenCDF is the indirect toxic
effect through the enchanced metabolic activation of
certain xenobiotics, which is catalyzed by particular
forms of cytochrome P-450. We recently reported thatYOSHIMURA ET AL.
PenCB produced a marked increase in both cytochrome
P-450 (448) content and N4-hydroxylation of sulfanil-
amide in the kidneys of rats which should stimulate
toxic effects of sulfanilamide to the kidneys (5). It
should be noted in this connection that DT-diaphorase,
an enzyme inducible with MC-type PCBs (2), is known
to catalyze not only the reduction of various quinones
(6), but also the reduction ofthe famous precarcinogen,
4-nitroquinoline N-oxide (4-NQO) to a proximate car-
cinogen, 4-hydroxylaminoquinoline N-oxide (4-HAQO)
(7).
The present paper describes the marked induction of
liver microsomal cytochrome P-450 (448) and cytosolic
DT-diaphorase to cause, respectively, possible dis-
turbance of steroid homeostasis and promotion of
carcinogenicity of4-NQO inratspretreated with PenCB
and PenCDE For studies on steroid metabolism,
progesterone and testosterone were selected as repre-
sentative substrates.
Materials and Methods
Chemicals
Kanechlor (KC)-400, a Japanese PCB preparation
with 48% chlorine content, was supplied bythe Ministry
ofHealth and Welfare ofJapan. PenCB was synthesized
as reported previously (8). 2,4,5,2',4',5'-Hexachloro-
biphenyl (HCB) was purchased from Analab, Inc.
(North Haven, CT). The PCDF congeners were gener-
ously donated by Dr. Y Masuda, Daiichi College of
Pharmaceutical Sciences (Fukuoka). 4-14C-Pro-
gesterone and -testosterone (specific radioactivity, 59
mCi/mmole) werepurchasedfromNewEnglandNuclear
Corp. (Boston, MA). Unlabeled steroids and metabo-
lites were obtained from Nakarai Chemicals, Ltd.
(Tokyo) and Steraloids, Inc. (Wilton, NH), except for
2a-, 60-, 7a- and 16a-hydroxytestosterone, which were
kindly donated by Dr. Y. Nakamura, Shionogi & Co.,
Ltd. (Osaka). 4-NQO, 4-HAQO and 4-aminoquinoline
N-oxide (4-AQO) were kindly given by Dr. S. Saeki,
Faculty ofPharmaceutical Sciences, Kyushu University
(Fukuoka). All otherchemicals used were ofthe highest
quality commercially available.
Animal Treatment
All PCBs and PCDFs were dissolved in corn oil and
injected IP into male Wistar rats weighing about 100 g.
PB in saline and MC in corn oil were injected IP once a
day for three consecutive days. Control animals were
injected with vehicle alone (2 mL/kg). Following fasting
for 18 hr, the animals were killed by decapitation 5 days
after the injection ofPCBs and PCDFs and 24 hr after
the last injection of PB and MC. Day 5 is the time in
which optimal induction ofthe MFO has been observed
after pretreatment with PCBs (9).
Enzyme Preparation
The homogenate prepared with three volumes of0.25
M sucrose containing 0.1 mM EDTA and 10 mM
Tris-HCl (pH 7.4) was centrifuged at 9000g for 20
min. The resultant 9000g supernatant was centrifuged
at 105,000g for 60 min. The pellet washed once with
isotonic KCl wasresuspended inTris-sucrose bufferand
used for steroid metabolism studies. For 4-NQO reduc-
tion, 9000g supernatants of liver, lung and skin which
were prepared similarly as above from the correspond-
ing 20% homogenate were used as the enzyme sources.
The skin sample was 2 cm2 of shaved skin from the
abdomen.
Enzyme Assays
SteroidMetabolism. The incubation mixture con-
sisted ofmicrosomes (about 3 mg ofprotein), 200 ,ug of
14C-steroid (0.4 ,uCi), 3.6 mM MgCl2, 0.5 mM NADPE
6 mM glucose-6-phosphate (G-6-P), 5 units of G-6-P
dehydrogenase and 50 mM Tris-HCl (pH 7.4) to make a
final volume of5 mL. Incubation was usually carried out
at 37°C for 10 min following a preincubation of 1 min
without an NADPH-generating system. The metabo-
lites extracted with ethyl acetate were redissolved in
small amounts of methanol and filtered through a
membrane filter of 0.45 jim pore size. An aliquot
(50-100 jiL) of the filtrate (0.2 mL) was applied to a
HPLC (Waters Assoc., Inc., Milford, MA, Model ALC
202/401) equippedwith6000Apump, asolventprogram-
mer type 660 (Waters Assoc.) and a radioactivity
monitor, BL 503 (Berthold, Wildbad, Germany). Sam-
ples were chromatographed on a Radial-PAK A column
(Waters Assoc., reversed phase) by stepwise elution
with 30% and 45%, or 25% and 35% tetrahydrofuran in
water (v/v), respectively, for progesterone or testoster-
one metabolites at a flow rate of 3 mL/min. The
metabolites were identified by their retention volumes
on HPLC relative to reference standards orby compari-
son of their Rf values on TLC and GC/MS fragmenta-
tion patterns with the reported data. A quantitative
determination of the metabolites was carried out by
measuring absorbance at 254 nm or radioactivity
(Packard, Model 3375 liquid scintillation counter) ofthe
corresponding peaks on HPLC.
4NQO Reduction. The DT-diaphorase activity was
determined accordingtothemethod ofErnster et al. (6)
by measuring the initial rate of decrease ofabsorbance
at 600 nm in the incubation of0.08 mM DCPIP, 0.15 mM
NADPH, 0.33 mM KCN and 50 mM Tris-HCl buffer
(pH 7.4) with 2 to 10 ,uL of 9000g supernatant of the
tissue homogenate at 25°C. Activity of 4-NQO reduc-
tion was also determined according to the methold of
Sugimura et al. (10) by measuring the initial rate of
decrease of absorbance at 340 nm in the incubation of
0.8 mM 4-NQO, 0.15 mM NADPH and 50 mM phos-
phate buffer (pH 7.0) with 2 to 10 ,iL of 9000g
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FIGURE 1. Effects ofpretreatment with phenobarbital, 3-methylcholanthrene and PCBs onmetabolismof(A) progesterone and (B) testosterone
with rat liver microsomes. From Yoshihara et al. (16). Experimental conditions as described in Materials and Methods. The activity is
expressed relative to that ofthe control group indicated below (the mean ± SD offour rats). ND = not detectable; the asterisk (*) denotes a
value significantly different from the control, p < 0.05. Control activity of progesterone metabolism (A): ( ZZsA) 16a-OH, 6.93 + 1.52
nmole/mg protein/ min; (_) 7ac-OH, 3.34 ± 1.16 nmole/mg protein/min; (B~) 61, 14.81 ± 1.03 nmole/mg protein/min. (r 1) 5a-,
21.13 ± 9.91 nmole/mg protein/min. Control activity of testosterone metabolism (B): (E2z=) 16cc-OH, 8.06 ± 1.79 nmole/mg protein/ min;
(_) 7a-OH, 6.70 ± 0.86nmole/mgprotein/min; (S ) 6,B-OH, 19.12 ± 1.19 nmole/mgprotein/min; (EI J) 5cc, 17.77 ± 8.25 nmole/mg
protein/min.
supernatant at 30°C. Dicumarol (0.1 mM) was used for
the inhibition experiment. Protein was determined
according to the method of Lowry et al., bovine serum
albumin being used as a standard (11).
Purification of Cytochrome P-450
Isozymes
Liver microsomes ofrats pretreated with PenCB at a
single IP dose of 5 mg/kg were solubilized with cholic
acid and partially purified by aminooctyl Sepharose 4B
according to the method of Imai and Sato (12). The
resultant fractions of cytochrome P-450 were further
chromatographed through a DE-52 cellulose column by
themethod ofWarneret al.(13) with somemodifications,
followed by hydroxyapatite and DEAE-Sephacel columns.
Extraction and Determination of PenCB
in Rat Liver
Liver lipids extracted from homogenate with a sol-
vent mixture of chloroform and methanol (2:1,v/v)
according to the method of Folch et al. (14), were
dissolved in n-hexane, and PenCB in this solution was
determined byECD-gas chromatography (column: 3 mm
x 1.7 m, 1.5% OV-17 on Chromosorb W; carrier gas: N2;
column temperature: 190°C).
Results
Effects of PCBs and PCDFs on Steroid
Metabolism by Liver Microsomes
In vitro metabolism of 14C-progesterone and 14C-tes-
tosterone was first conducted with liver microsomes of
rats pretreated with various inducers such as PB, MC
and PCBs (KC-400 as mixed type, HCB as PB-type and
PenCB as MC-type), analyzing the metabolites by
HPLC. The results as relative activities are shown in
Figure 1.
Pretreatment with PB, hexachlorobiphenyl (HCB)
and KC-400 increased the 16a-, 7a- and 6p-hydroxyla-
tions of progesterone 1.5- to 2-fold compared with the
control. MC pretreatment also enhanced the 16a- and
7a- hydroxylations but did not affect the 6p-hydroxyla-
tion. A similar tendency was observed in the metabo-
lism of testosterone. The most unique change of the
metabolic profile ofboth steroids was demonstrated by
pretreatment with the highly toxic PenCB. This PCB
enhanced the 7a-hydroxylation more than 3-fold , but,
unlike other inducers, the hydroxylations at 16ax- and
6,-positions ofboth steroids were strongly depressed to
less than 20% of the control. The 2a-hydroxylation of
progesterone and formation of androstenedione from
testosterone were also decreased only by PenCB
pretreatment, but notby any other pretreatments (data
not shown in this figure). In addition, apart from these
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Table 1. Effects of pretreatment with 2,3,4,7,8-pentachlorodi
benzofuran (PenCDF) on metabolism of progesterone with rat
liver microsomes.a
Progesteronemetabolized, nmole/mgprotein/10min.
PenCDF pretreatment
Metabolite Control (0.1 mg/kg)
16a-OH 6.93 ± 1.52 3.10 ± 0.83*
7ca-OH 3.34 ± 1.16 8.60 ± 4.00*
6a-OH 14.81 ± 1.03 8.81 ± 2.90*
2a-OH 7.31 ± 4.01 0.93 ± 0.38*
5a-Pregnane-3,20-dione 21.13 ± 9.91 13.31 ± 5.15
Total metabolism 68.11 ± 8.23 37.84 ± 11.48*
aFrom Yoshihara et al. (16). Experimental conditions were
described in Materials and Methods. The total metabolism was
calculated from the amount of substrate disappearing. The value
represents the mean ± SD of four rats.
Significantly different from the control, p<0.05.
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FIGURE 2. Effectsofpretreatmentwithpolychlorinateddibenzofuran
(PCDF) congeners on 7a- and 2a-hydroxylation of progesterone
with rat liver microsomes. From Yoshihara et al. (16). The
microsomes were obtained from the pooled liver of four rats per
group pretreated with respective PCDF congener at a single dose
indicated.
hydroxylations, 5a-reduction of both steroids to 5a-
pregnane-3,20-dione andto5a.-androstane-17,B-ol-3-one,
respectively, were decreased more markedly by PenCB
than other inducers.
A very similar depressing effect on hydroxylations at
the 16a-, 60- and 2a-positions and 5a-reduction of
progesterone were demonstrated by the microsomes
obtained from rats pretreated with PenCDF at a single
dose of 0.1 mg/kg (Table 1). The 7a-hydroxylation was
selectively increased, but the summation ofthis unique
effect of PenCDF resulted in a marked depression of
total metabolism, same as the case ofPenCB pretreat-
ment.
Contrary to this highly toxic PenCDF, all other
PCDFs that are nontoxic and non-MC-type inducers
never produced such a dramatic change of steroid
metabolism. As indicated in Figure 2, either 7a- or
Table 2. Catalytic activity of liver cytochrome P-450 isozymes
from rats pretreated with 3,4,5,3',4'-pentachlorobiphenyl
(PenCB).a
Catalytic activity, nmole product/nmole P-450/min
Low spin High spin
Hydroxylation P-448 P-448 P-452
Benzo[a]pyrene, 3-OH 2.12 0.08 0.08
Testosterone
7ot-OH 0.09 NDb 10.92
16a-OH Trace Trace 0.43
6,B-OH 0.72 0.28 0.48
Estradiol, 2-OH 1.66 17.05 0.65
aThe activity is expressed as nmoles product/nmole P-450/min.
Benzo[alpyrene 3-hydroxylase and steroid hydroxylases were as-
sayed as described previously (2) and in Materials and Methods, res-
pectively.
bND = not detected.
2a-hydroxylation ofprogesterone was strongly affected
only by pretreatment with PenCDF.
Separation and Purification of
Cytochrome P-450 Isozymes from Liver
Microsomes of Rats Pretreated with
PenCB
The very interesting phenomenon described above
could be explained at least in part by a characteristic
change of relative contents of cytochrome P-450 iso-
zymes after pretreatment with the potent MC-type
PenCB and PenCDF. In orderto confirmthis possibility,
separation and purification of strongly induced cyto-
chrome P-450 isozymes, some of which may preferen-
tially be concerned with 7a-hydroxylation of the
steroids, were undertaken.
SDS-polyacrylamide gel electrophoresis of liver mi-
crosomal protein from rats pretreated with PenCB
showed a marked change ofpattern in comparison with
that ofthe control. Among various isozymes, the three
major strongly induced cytochrome P-450 species were
then purified by the method of Imai and Sato (12) and
Warner et al. (13) with some modifications. The first
one, the most highly induced cytochrome P-450, was a
high-spin type showing the absorption maximum ofthe
CO-difference spectrum at 448 nm (a high-spin P-448).
Since this cytochrome showed a high activity of 2-hy-
droxylation ofestradiol on reconstitution for MFO (see
Table 2), it seemed very likely that this was identical
with Levin's P-450d(15), although the molecular weight
in the SDS-gel system was different (our sample,
54,000; Levin's, 52,000).
The second cytochrome purified was a low-spin P-448
which had a molecular weight of about 56,000 in the
SDS-gel system and was most concerned with 3-hy-
droxylation of benzo[a]pyrene. These two cytochrome
P-448s, however, were found to play only a minor role in
7a-hydroxylation of testosterone (Table 2). The third
isozyme that showed an absorption maximum of the
CO-difference spectrum at 452 nm (P-452) and had a
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FIGURE 3. Thin-layer chromatogram of reduction product of
4-nitroquinoline N-oxide (4-NQO) with rat liver 9001g super-
natant. From Yoshimura et al. (17). Solvent system: isoamyl
alcohol-acetone-H20 (4:2:1, v/v)
molecular weight of 48,000 in the SDS-gel system was
found to catalyze 7a-hydroxylation oftestosterone with
a high activity of about 10 nmole/mmole P-450/min on
reconstitution.
Table 3. Activities ofDT-diaphorase and4-nitroquinolineN-oxide
(4-NQO) reductase in 9000g supernatant ofthe liver, lungand skin
of rats pretreated with 3,4,5,3',4'-pentachlorobiphenyl (PenCB).a
DCPIP activity, 4NQO activity,
Tissue Treatment p.moleb p.molec
Liver Control 0.652 ± 0.038 0.381 ± 0.026
PenCB 6.830 ± 0.801 3.281 ± 0.513
Lung Control 0.311 ± 0.052 0.162 ± 0.029
PenCB 0.879 ± 0.087 0.457 ± 0.052
Skin Control 0.060 ± 0.008 0.132 ± 0.016
PenCB 0.309 ± 0.038 0.285 ± 0.037
aFrom Yoshimura et al. (17). The value represents the mean ± SD
of four rats.
bDichlorophenolindophenol (DCPIP) reductase ,umole/mg pro-
tein/min.
CNADPH oxidized, ,u.mole/mg protein/min.
Identification of Reduction Product of
4-NQO by Rat Liver 9000g Supernatant
In order to confirm the previous result ofSugimura et
al. (7), 4-NQO was incubated with liver 9000g superna-
tant from untreated rats in the presence of NADPH at
37°C for 1 min. As illustrated in Figure 3, the thin-layer
chromatogram of the ethyl acetate extract clearly
showed formation of4-HAQO as sole reduction product.
4-AQO could not be detected at all under the condi-
tions used. A larger spot corresponding to 4-HAQO was
observed when microsomes from rats pretreated with
PenCB were used as the enzyme source.
Enhancement of Activities of DT-
Diaphorase and 4-NQO Reduction in
Liver, Lung and Skin of Rats Pretreated
with PenCB
Activities of DT-diaphorase (DCPIP reduction) and
4-NQOreduction were determined inthe9000g superna-
tant of liver, lung and skin of rats pretreated with
PenCB at a single IP dose of 1.0 mg/kg. As shown in
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Thble 3, DT-diaphorase activity increased about 10- ,3-
and 5-fold, respectively, in liver, lungand skin on PenCB
pretreatment. Along with this induction, activities of
4-NQO reduction were also increased about 9-, 3- and
2-fold, respectively. It should be noticed that these
activities were completely inhibited by addition of 0.1
mM dicumarol, a specific inhibitor of DT-diaphorase in
the incubation mixture, indicating that the reduction of
4-NQO in this in vitro system was catalyzed solely by
DT-diaphorase.
To confirm more precisely the parallel increase ofthe
two activities, individual values of reduction activities
ofDCPIP and 4-NQO in the control and PenCB-treated
rats were compared. As indicated in Figure 4, 4-NQO
reduction activities correlated well with DCPIP reduc-
tion activities in all the three organ preparations, and
the ratios of both reduction activities were almost
constant among the three organs. The above findings
suggest that the same enzyme (DT-diaphorase) that can
be induced by PenCB treatment is concerned with
reduction of4-NQO to a proximate carcinogen, 4-HAQO
in rats. These data were not shown in this paper, but a
similar effect was also obtained from the experiments
with PenCDE
0. 5
0
Skin
pmoles DCPIP red./min/mg protein
FIGURE 4. Correlation between activities of DT-diaphorase and 4-nitroquinoline N-oxide (4-NQO) reductase. From Yoshimura et al. (17).
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FIGURE 5. Time course of 3,4,5,3',4'-pentachlorobiphenyl (PenCB)
accumulation in the liver ofrats given asingle dose of0.5mg/kg.
Persistency of PenCB and PenCDF in
Rat Liver
The induction effects of the highly toxic MC-type
PenCB and PenCDF are very strongand longlasting. It
is, therefore, important to learn the time course ofthe
concentration of PenCB and PenCDF in the liver. The
study was first performed by using the liver of rats
orally administered PenCB at a single dose of 0.5
mg/kg. As illustrated in Figure 5, about 68% ofthe dose
accumulated in the liver 5 days afterthe administration.
This high level of accumulation persisted over a long
period, and over 20% ofthe dose was still retained inthe
liver after 30 days. Such a surprisingly high affinity to
the liver is also seen in the case of PenCDF even more
markedly (data not shown), but not in any other PCBs
including HCB, which is a typical PB-type inducer and
does not have a high toxicity.
Discussion
PCBs and PCDFs are closely related families of
compounds, similar not only in structure, but also in
biological and toxicological nature (1). Among these,
PenCB and PenCDF are most unique with respect to
inductive effect and toxicity. Both compounds reveal a
significantly potent MC-type induction and acute toxic-
ity at a single dose as low as 0.1 mg/kg (PenCB) or 0.01
mg/kg (PenCDF) in rats (3). The present study has
demonstrated further the characteristic properties of
PenCB and PenCDF, using effects on steroid metabo-
lism and on 4-NQO reduction as the biological and
possible toxic indicators (16,17).
The remarkable effect ofPenCB and PenCDF on the
metabolism of progesterone and testosterone was an
increase of 7a-hydroxylation and decrease of 16a-, 61-
and 2a-hydroxylations. Pretreatment with these induc-
ers caused also depression of 5a-reduction which is a
rate-limiting step in catabolism ofA4-steroids, resulting
in a marked decrease of total metabolism of both
steroids. Similar effect has been reported by pretreat-
ment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
(18,19).
This unique change of steroid metabolism might be
due to qualitative and quantitative changes of cyto-
chrome P-450 isozymes. The present paper provided
evidence to explain an increase of 7a-hydroxylation by
purification ofpreferentially induced cytochrome P-452.
Both PenCB and PenCDF have a very high persistency
inthe liver, and therefore, mayafford a significant effect
on steroid metabolism in vivo not only with a high
potency but also over a long period, ifanimals are once
exposed to appreciable amounts of these compounds.
Based on these findings, it is very likely that a
disturbance in steroid homeostasis causedbythe change
of relative contents of cytochrome P-450 isozymes is
responsible for the endocrine symptoms seen in Yusho
patients.
The marked increase of 4-NQO reduction activity is
parallel with a potent induction of DT-diaphorase in
several organs of rats by pretreatment with PenCB is
also important with respect to possible promotion of
carcinogenicity of4-NQO. These experiments, however,
were conducted only in an in vitro system. It is,
therefore, impossible at present to conclude whether or
not exposure to PenCB or PenCDF could really pro-
mote carcinogenicity of 4-NQO. In vivo studies on this
line are progressing in this laboratory, and the results
will be reported elsewhere in the near future.
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